Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Science Translational Medicine|December 16, 2014
Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenaseYan Liu, Aarti Asnani, Lin Zou, et al.Science Translational Medicine|May 28, 2010
Metabolic signatures of exercise in human plasmaGregory D Lewis, Laurie Farrell, Malissa J Wood, et al.The New England Journal of Medicine|March 4, 2011
Diuretic strategies in patients with acute decompensated heart failureG Michael Felker, Kerry L Lee, David A Bull, et al.The New England Journal of Medicine|November 8, 2012
Ultrafiltration in decompensated heart failure with cardiorenal syndromeBradley A Bart, Steven R Goldsmith, Kerry L Lee, et al.Journal of the American College of Cardiology|July 4, 2006
A novel locus for dilated cardiomyopathy, diffuse myocardial fibrosis, and sudden death on chromosome 10q25-26Patrick T Ellinor, Sabine Sasse-Klaassen, Susanne Probst, et al.Circulation|May 20, 2015
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) StudyMichael M Givertz, Kevin J Anstrom, Margaret M Redfield, et al.JAMA|March 13, 2013
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trialMargaret M Redfield, Horng H Chen, Barry A Borlaug, et al.JAMA|November 20, 2013
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trialHorng H Chen, Kevin J Anstrom, Michael M Givertz, et al.Nature Genetics|April 16, 2013
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disordersMarcel den Hoed, Mark Eijgelsheim, Tõnu Esko, et al.Pageof 9